Recombinant Mouse TNFRSF12A/TWEAKR Protein, Active
Beta LifeScience
SKU/CAT #: BLK-01261P-100UG

Mouse TNFRSF12A on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Mouse TNFRSF12A/TWEAKR Protein, Active
Beta LifeScience
SKU/CAT #: BLK-01261P-100UG
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Mouse TNFRSF12A/TWEAKR Protein is expressed from HEK293 with hFc tag at the N-Terminus.It contains Glu28-Per80. |
Purity | > 95% as determined by Tris-Bis PAGE |
Accession | Q9CR75 |
Target Symbol | TNFRSF12A/TWEAKR |
Synonyms | FGF-inducible 14; Fgfrp2; TNFRSF12A; FN14; CD266; TWEAKR |
Species | Mouse |
Expression System | HEK293 |
Tag | N-hFc |
Expression Range | Glu28-Per80 |
Mol. Weight | The protein has a predicted MW of 32.8 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | The affinity constant of 0.15 nM as determined in SPR assay (Biacore T200). Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | Thyroid cancer (TC) is the most well-known endocrine neoplasia as well as a common malignant tumor in the head and neck.TNFRSF12A expression may be a potential useful prognostic molecular biomarker of bad survival in thyroid cancer, in addition, PPAR signaling pathway, insulin signaling pathway, mTOR signaling pathway may be the key pathway controlled by TNFRSF12A in thyroid cancer. Further experimental ought to be performed to demonstrate the biologic effect of TNFRSF12A. |